DOCSLIB.ORG

Vasohibin-1 Is Identified As a Master-Regulator of Endothelial Cell

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vasohibin-1 Is Identified As a Master-Regulator of Endothelial Cell Affara et al. BMC Genomics 2013, 14:23 http://www.biomedcentral.com/1471-2164/14/23 RESEARCH ARTICLE Open Access Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis Muna Affara1, Debbie Sanders1, Hiromitsu Araki2, Yoshinori Tamada3, Benjamin J Dunmore1, Sally Humphreys1, Seiya Imoto3, Christopher Savoie2, Satoru Miyano3, Satoru Kuhara4, David Jeffries5, Cristin Print6,7* and D Stephen Charnock-Jones1,8* Abstract Background: Apoptosis is a critical process in endothelial cell (EC) biology and pathology, which has been extensively studied at protein level. Numerous gene expression studies of EC apoptosis have also been performed, however few attempts have been made to use gene expression data to identify the molecular relationships and master regulators that underlie EC apoptosis. Therefore, we sought to understand these relationships by generating a Bayesian gene regulatory network (GRN) model. Results: ECs were induced to undergo apoptosis using serum withdrawal and followed over a time course in triplicate, using microarrays. When generating the GRN, this EC time course data was supplemented by a library of microarray data from EC treated with siRNAs targeting over 350 signalling molecules. The GRN model proposed Vasohibin-1 (VASH1) as one of the candidate master-regulators of EC apoptosis with numerous downstream mRNAs. To evaluate the role played by VASH1 in EC, we used siRNA to reduce the expression of VASH1. Of 10 mRNAs downstream of VASH1 in the GRN that were examined, 7 were significantly up- or down-regulated in the direction predicted by the GRN.Further supporting an important biological role of VASH1 in EC, targeted reduction of VASH1 mRNA abundance conferred resistance to serum withdrawal-induced EC death. Conclusion: We have utilised Bayesian GRN modelling to identify a novel candidate master regulator of EC apoptosis. This study demonstrates how GRN technology can complement traditional methods to hypothesise the regulatory relationships that underlie important biological processes. Keywords: Vasohibin, HUVEC, Bayesian, Gene regulatory network Background generated by modern high throughput methods such as The explosion of systems biology in recent years, facili- microarrays or RNAseq, to holistically model interac- tated by sequencing of the human genome [1,2] and the tions between molecules in cells and tissues. GRN are development of high throughput methods to rapidly usually displayed as directed graphs - nodes represent characterise and quantify biological systems [3-6], has mRNA abundance and edges represent some form of promoted understanding of complex biological and regulatory relationship between the nodes. The reverse pathological processes. Gene regulatory networks (GRN) engineering of GRN from gene expression data has been represent a systems biology approach, taking advantage used to understand molecular interactions in both bac- of the growing number of RNA abundance data sets terial and lower eukaryotic organisms, as well as in more complex mammalian systems. GRN employ simple cor- * Correspondence: [email protected]; [email protected] relation [7] or Boolean [8] methods, algorithms based on 6 Department of Molecular Medicine and Pathology, School of Medical mutual information [9,10] as well as Bayesian methods. Sciences, University of Auckland, Auckland, New Zealand 1Department of Obstetrics and Gynaecology, University of Cambridge, The Computational frameworks have been generated to sim- Rosie Hospital, Robinson Way, Cambridge CB2 0SW, U.K ultaneously perform several types of GRN analysis [11]. Full list of author information is available at the end of the article © 2013 Affara et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Affara et al. BMC Genomics 2013, 14:23 Page 2 of 12 http://www.biomedcentral.com/1471-2164/14/23 Bayesian GRN are in theory especially powerful for in- the more likely it is that accurate predictions can be ference of causal relationships between mRNAs in noisy made by GRN. Therefore, in this current study we have microarray data [12,13]. In Bayesian GRN, the probabil- expanded our previous analysis by combining triplicated ity of the abundance of each mRNA node is modelled eight time point SFD time course data with a much lar- using a function that takes as its inputs the abundance ger library of EC siRNA disruptant microarray data, of the node's parent mRNAs. The edges in a Bayesian which was generated from the knockdown of 351 differ- GRN can represent hidden protein, non-coding RNA or ent mRNA transcripts that encode proteins with a broad metabolite-based regulatory relationships [14]. There- range of functions in EC [11]. This expanded analysis fore, Bayesian GRN can in theory capture information identified numerous GRN master regulators, many of about a subset of the complex cellular regulatory cir- which were already known to play important roles in EC cuitry [15]. Many GRN developed to date have had a biology. However, we noted one major master regulator ‘scale free’ structure [10,16], in which a small number of RNA named Vasohibin-1 (VASH1) that had not at the “hub” RNAs can be identified that are connected to large time been extensively studied in EC apoptosis. There- numbers of downstream RNAs in the networks. These fore, we investigated the function of VASH1 in regulat- hub RNAs are candidate master-regulators of transcrip- ing mRNA abundance and in the process of EC tion and other cellular processes. Their identification is apoptosis. We targeted VASH1 using siRNA and then based on relationships in the data between the hub RNA used quantitative polymerase chain reaction (PCR) to and their downstream RNAs in the GRN structure, examine the abundance of 10 of the 31 mRNAs directly which are usually referred to as "children". Therefore, downstream of VASH1 in the GRN. 7 of these 10 the amount of data behind the identification of hub mRNAs were significantly up- or down-regulated in the RNAs is much greater than the amount of data behind direction predicted by the GRN when VASH1 expression the identification of individual edges, and correct identi- was reduced. We also show that VASH1 is required for fication of hubs may be easier in theory than the correct the apoptotic response in EC treated with SFD. identification of individual edges. Apoptosis is pivotal for normal EC function [17], and Methods the dysregulation of endothelial apoptosis is a key step Cell culture and siRNA transfection in the development of numerous pathologies [18], includ- Umbilical cords were collected with written informed ing cardiovascular disease [19-21] and tumourogenesis maternal consent and the approval of the Cambridge [22-25]. Understanding the regulatory events occurring (UK) Research Ethics Committee. Human Umbilical during this process in a holistic manner may provide Vein ECs (HUVECs) were isolated by collagenase diges- insight into normal vascular development and mainten- tion, as previously described [31]. Cells were cultured in ance, as well as vascular pathologies. Although there has fully supplemented media without antibiotics (basal been extensive characterisation of the EC proteins EBM-2 with a propriety mix of heparin, hydrocortisone, involved in apoptotic pathways [26-28], there have been epidermal growth factor, fibroblast growth factor, vascu- fewer investigations into regulation of the transcriptome lar endothelial growth factor, 2% foetal calf serum (FCS) in ECs undergoing apoptosis [17,29]. Lonza, Cambridge, UK), at 37°C/5% CO2. To carry out To begin to address this issue, our group have siRNA transfection, HUVEC pools consisting of 10 bio- previously used Bayesian GRN to identify molecular logical isolates (of equal contribution) were prepared interactions involved in survival factor deprivation (SFD)- using passage 3 cultured cells. The HUVEC pools were induced EC apoptosis and cell cycle arrest [18]. This plated in 6-well plates at 2.5 × 105 per well and left for previous study used micorarray data over a triplicated 24hrs until approximately 70% confluent. siRNA transfec- eight time point SFD time course. Previous studies have tion was carried out using pools of four siRNA duplexes illustrated the value of supplementing time series data from Dharmacon Inc (Lafyette, Colorado, USA) and the with gene disruption data (e.g. [30]). Since at the time we SiFectamine transfection reagent (ICVEC, London, UK) were especially interested in regulation of the cell cycle, in according to the manufacturer’s instructions. this previous work the time series data was supplemented by eight microarrays from EC cultures treated with RNA processing and microarray preparation W siRNAs targeting molecules associated with the cell cycle. RNA was extracted using TRIzol reagent (Invitrogen, This analysis identified several GRN master regulator London, UK). RNA quality was assessed using the RNAs including the γ-amino butyric acid (GABA)- Agilent 2100 bioanalyser. Biotin labelled cRNA was gen- Receptor Associated Protein (GABARAP) [18]. erated and hybridised on the CodeLink Human Uniset In theory, the greater the volume of high-quality 20K microarrays following the manufacturer’s instruc- siRNA data used to supplement time course data, and tions (Applied Microarrays, Tempe,
Load more

Recommended publications
  • Interoperability in Toxicology: Connecting Chemical, Biological, and Complex Disease Data
    INTEROPERABILITY IN TOXICOLOGY: CONNECTING CHEMICAL, BIOLOGICAL, AND COMPLEX DISEASE DATA Sean Mackey Watford A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Gillings School of Global Public Health (Environmental Sciences and Engineering). Chapel Hill 2019 Approved by: Rebecca Fry Matt Martin Avram Gold David Reif Ivan Rusyn © 2019 Sean Mackey Watford ALL RIGHTS RESERVED ii ABSTRACT Sean Mackey Watford: Interoperability in Toxicology: Connecting Chemical, Biological, and Complex Disease Data (Under the direction of Rebecca Fry) The current regulatory framework in toXicology is expanding beyond traditional animal toXicity testing to include new approach methodologies (NAMs) like computational models built using rapidly generated dose-response information like US Environmental Protection Agency’s ToXicity Forecaster (ToXCast) and the interagency collaborative ToX21 initiative. These programs have provided new opportunities for research but also introduced challenges in application of this information to current regulatory needs. One such challenge is linking in vitro chemical bioactivity to adverse outcomes like cancer or other complex diseases. To utilize NAMs in prediction of compleX disease, information from traditional and new sources must be interoperable for easy integration. The work presented here describes the development of a bioinformatic tool, a database of traditional toXicity information with improved interoperability, and efforts to use these new tools together to inform prediction of cancer and complex disease. First, a bioinformatic tool was developed to provide a ranked list of Medical Subject Heading (MeSH) to gene associations based on literature support, enabling connection of compleX diseases to genes potentially involved.
    [Show full text]
  • Angiogenesis Interactome and Time Course Microarray Data Reveal the Distinct Activation Patterns in Endothelial Cells
    Angiogenesis Interactome and Time Course Microarray Data Reveal the Distinct Activation Patterns in Endothelial Cells Liang-Hui Chu1*, Esak Lee1, Joel S. Bader1,2, Aleksander S. Popel1,3 1 Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, 2 High-Throughput Biology Center, Johns Hopkins University, Baltimore, Maryland, United States of America, 3 Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America Abstract Angiogenesis involves stimulation of endothelial cells (EC) by various cytokines and growth factors, but the signaling mechanisms are not completely understood. Combining dynamic gene expression time-course data for stimulated EC with protein-protein interactions associated with angiogenesis (the ‘‘angiome’’) could reveal how different stimuli result in different patterns of network activation and could implicate signaling intermediates as points for control or intervention. We constructed the protein-protein interaction networks of positive and negative regulation of angiogenesis comprising 367 and 245 proteins, respectively. We used five published gene expression datasets derived from in vitro assays using different types of blood endothelial cells stimulated by VEGFA (vascular endothelial growth factor A). We used the Short Time-series Expression Miner (STEM) to identify significant temporal gene expression profiles. The statistically significant patterns between 2D fibronectin and 3D type I collagen substrates for telomerase-immortalized EC (TIME) show that different substrates could influence the temporal gene activation patterns in the same cell line. We investigated the different activation patterns among 18 transmembrane tyrosine kinase receptors, and experimentally measured the protein level of the tyrosine-kinase receptors VEGFR1, VEGFR2 and VEGFR3 in human umbilical vein EC (HUVEC) and human microvascular EC (MEC).
    [Show full text]
  • Electroporation of Mice Zygotes with Dual Guide RNA/Cas9 Complexes for Simple and Efficient Cloning-Free Genome Editing
    www.nature.com/scientificreports Correction: Author Correction OPEN Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efcient Received: 8 September 2017 Accepted: 11 December 2017 cloning-free genome editing Published: xx xx xxxx Marie Teixeira1, Bénédicte F. Py2, Christophe Bosc3,4, Daphné Laubreton 2, Marie-Jo Moutin3,4, Jacqueline Marvel 2, Frédéric Flamant5 & Suzy Markossian5 In this report, we present an improved protocol for CRISPR/Cas9 genome editing in mice. The procedure consists in the electroporation of intact mouse zygotes with ribonucleoprotein complexes prepared in vitro from recombinant Cas9 nuclease and synthetic dual guide RNA. This simple cloning-free method proves to be extremely efcient for the generation of indels and small deletions by non-homologous end joining, and for the generation of specifc point mutations by homology-directed repair. The procedure, which avoids DNA construction, in vitro transcription and oocyte microinjection, greatly simplifes genome editing in mice. Since its adaptation to mammalian cells1,2, CRISPR/Cas9 genome editing has become a key element of the genetic toolbox in mice3,4. Te method relies on Streptococcus pyogenes Cas9 (SpCas9), a RNA-guided DNA endonu- clease. Annealing between genomic DNA and the 5′-end of the guide RNA defnes the position of the cleavage site by SpCas9, provided that the homologous genomic DNA sequence is immediately followed by a so-called protospacer adjacent motif (PAM: 5′-NGG-3′). SpCas9 cleaves both DNA strands 3 nucleotides (nt) upstream to the PAM. Terefore, the sequence of the frst 20 nt of the guide RNA defnes the genomic location of the double strand break5.
    [Show full text]
  • Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
    Hindawi International Journal of Genomics Volume 2017, Article ID 2913648, 13 pages https://doi.org/10.1155/2017/2913648 Research Article Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML 1,2,3 1 2 Mirazul Islam, Zahurin Mohamed, and Yassen Assenov 1Pharmacogenomics Lab, Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia 2Computational Epigenomics Group, Division of Epigenomics and Cancer Risk Factor, German Cancer Research Center, Heidelberg, Germany 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Correspondence should be addressed to Zahurin Mohamed; [email protected] and Yassen Assenov; [email protected] Received 14 November 2016; Revised 21 March 2017; Accepted 18 April 2017; Published 20 June 2017 Academic Editor: Brian Wigdahl Copyright © 2017 Mirazul Islam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Acute myeloid leukemia (AML) is a haematological malignancy characterized by the excessive proliferation of immature myeloid cells coupled with impaired differentiation. Many AML cases have been reported without any known cytogenetic abnormalities and carry no mutation in known AML-associated driver genes. In this study, 200 AML cases were selected from a publicly available cohort and differentially analyzed for genetic, epigenetic, and cytogenetic abnormalities. Three genes (FLT3, DNMT3A, and NPMc) are found to be predominantly mutated. We identified several aberrations to be associated with genome-wide methylation changes. These include Del (5q), T (15; 17), and NPMc mutations. Four aberrations—Del (5q), T (15; 17), T (9; 22), and T (9; 11)—are significantly associated with patient survival.
    [Show full text]
  • A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion
    BASIC RESEARCH www.jasn.org A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion † ‡ | Annekatrin Aue,* Christian Hinze,* Katharina Walentin,* Janett Ruffert,* Yesim Yurtdas,*§ | Max Werth,* Wei Chen,* Anja Rabien,§ Ergin Kilic,¶ Jörg-Dieter Schulzke,** †‡ Michael Schumann,** and Kai M. Schmidt-Ott* *Max Delbrueck Center for Molecular Medicine, Berlin, Germany; †Experimental and Clinical Research Center, and Departments of ‡Nephrology, §Urology, ¶Pathology, and **Gastroenterology, Charité Medical University, Berlin, Germany; and |Berlin Institute of Urologic Research, Berlin, Germany ABSTRACT Grainyhead transcription factors control epithelial barriers, tissue morphogenesis, and differentiation, but their role in the kidney is poorly understood. Here, we report that nephric duct, ureteric bud, and collecting duct epithelia express high levels of grainyhead-like homolog 2 (Grhl2) and that nephric duct lumen expansion is defective in Grhl2-deficient mice. In collecting duct epithelial cells, Grhl2 inactivation impaired epithelial barrier formation and inhibited lumen expansion. Molecular analyses showed that GRHL2 acts as a transcrip- tional activator and strongly associates with histone H3 lysine 4 trimethylation. Integrating genome-wide GRHL2 binding as well as H3 lysine 4 trimethylation chromatin immunoprecipitation sequencing and gene expression data allowed us to derive a high-confidence GRHL2 target set. GRHL2 transactivated a group of genes including Ovol2, encoding the ovo-like 2 zinc finger transcription factor, as well as E-cadherin, claudin 4 (Cldn4), and the small GTPase Rab25. Ovol2 induction alone was sufficient to bypass the requirement of Grhl2 for E-cadherin, Cldn4,andRab25 expression. Re-expression of either Ovol2 or a combination of Cldn4 and Rab25 was sufficient to rescue lumen expansion and barrier formation in Grhl2-deficient collecting duct cells.
    [Show full text]
  • Facteur De Risque Génétique Aux Maladies Inflammatoires De L’Intestin Et Modulateur D’Inflammation
    Université de Montréal MAST3 : facteur de risque génétique aux maladies inflammatoires de l’intestin et modulateur d’inflammation par Catherine Labbé Département de sciences biomédicales Faculté de médecine Thèse présentée à la Faculté de médecine en vue de l’obtention du grade de doctorat en sciences biomédicales 5 août, 2011 © Catherine Labbé, 2011 Université de Montréal Faculté de médecine Cette thèse intitulée : MAST3 : facteur de risque génétique aux maladies inflammatoires de l’intestin et modulateur d’inflammation Présentée par : Catherine Labbé a été évaluée par un jury composé des personnes suivantes : Daniel Sinnett, président-rapporteur John D. Rioux, directeur de recherche Zoha Kibar, membre du jury Yohan Bossé, examinateur externe Gaëtan Mayer, représentant du doyen de la FES i Résumé La maladie de Crohn (MC) et la colite ulcéreuse (CU) sont des maladies inflammatoires chroniques du tube digestif qu’on regroupe sous le terme maladies inflammatoires de l’intestin (MII). Les mécanismes moléculaires menant au développement des MII ne sont pas entièrement connus, mais des études génétiques et fonctionnelles ont permis de mettre en évidence des interactions entre des prédispositions génétiques et des facteurs environnementaux - notamment la flore intestinale – qui contribuent au développement d’une dérégulation de la réponse immunitaire menant à l’inflammation de la muqueuse intestinale. Des études d’association pangénomiques et ciblées ont permis d’identifier plusieurs gènes de susceptibilité aux MII mais les estimations de la contribution de ces gènes à l’héritabilité suggèrent que plusieurs gènes restent à découvrir. Certains d’entre eux peuvent se trouver dans les régions identifiées par des études de liaison génétique.
    [Show full text]
  • Number 6 June 2014
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST -CNRS Volume 18 - Number 6 June 2014 The PDF version of the Atlas of Genetics and Cytogenetics in Oncology and Haematology is a reissue of the original articles published in collaboration with the Institute for Scientific and Technical Information (INstitut de l’Information Scientifique et Technique - INIST) of the French National Center for Scientific Research (CNRS) on its electronic publishing platform I-Revues. Online and PDF versions of the Atlas of Genetics and Cytogenetics in Oncology and Haematology are hosted by INIST-CNRS. Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST -CNRS Scope The Atlas of Genetics and Cytogenetics in Oncology and Haematology is a peer reviewed on-line journal in open access, devoted to genes, cytogenetics, and clinical entities in cancer, and cancer-prone diseases. It presents structured review articles (“cards”) on genes, leukaemias, solid tumours, cancer-prone diseases, and also more traditional review articles (“deep insights”) on the above subjects and on surrounding topics. It also present case reports in hematology and educational items in the various related topics for students in Medicine and in Sciences. Editorial correspondance Jean-Loup Huret Genetics, Department of Medical Information, University Hospital F-86021 Poitiers, France tel +33 5 49 44 45 46 or +33 5 49 45 47 67 [email protected] or [email protected] Staff Mohammad Ahmad, Mélanie Arsaban, Marie-Christine Jacquemot-Perbal, Vanessa Le Berre, Anne Malo, Carol Moreau, Catherine Morel-Pair, Laurent Rassinoux, Alain Zasadzinski. Philippe Dessen is the Database Director, and Alain Bernheim the Chairman of the on-line version (Gustave Roussy Institute – Villejuif – France).
    [Show full text]
  • Network Pharmacology and Molecular Docking Study on the Active
    www.nature.com/scientificreports OPEN Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy Mingxu Zhang1, Jiawei Yang1,2, Xiulan Zhao1, Ying Zhao1 & Siquan Zhu1,3* Diabetic retinopathy (DR) is a leading cause of irreversible blindness globally. Qidengmingmu Capsule (QC) is a Chinese patent medicine used to treat DR, but the molecular mechanism of the treatment remains unknown. In this study, we identifed and validated potential molecular mechanisms involved in the treatment of DR with QC via network pharmacology and molecular docking methods. The results of Ingredient-DR Target Network showed that 134 common targets and 20 active ingredients of QC were involved. According to the results of enrichment analysis, 2307 biological processes and 40 pathways were related to the treatment efects. Most of these processes and pathways were important for cell survival and were associated with many key factors in DR, such as vascular endothelial growth factor-A (VEGFA), hypoxia-inducible factor-1A (HIF-1Α), and tumor necrosis factor-α (TNFα). Based on the results of the PPI network and KEGG enrichment analyses, we selected AKT1, HIF-1α, VEGFA, TNFα and their corresponding active ingredients for molecular docking. According to the molecular docking results, several key targets of DR (including AKT1, HIF-1α, VEGFA, and TNFα) can form stable bonds with the corresponding active ingredients of QC. In conclusion, through network pharmacology methods, we found that potential biological mechanisms involved in the alleviation of DR by QC are related to multiple biological processes and signaling pathways. The molecular docking results also provide us with sound directions for further experiments.
    [Show full text]
  • Supplemental Figure 1 Grhl2 Binding Through Chip-Seq and Derived Target Genes by Combining Chip-Seq and Gene Expression Data
    A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion Annekatrin Aue,*† Christian Hinze,*‡ Katharina Walentin,* Janett Ruffert,* Yesim Yurtdas,*§| Max Werth,* Wei Chen,* Anja Rabien,§| Ergin Kilic,** Jörg-Dieter Schulzke,†† Michael Schumann,†† and Kai M. Schmidt-Ott*†‡ *Max Delbrueck Center for Molecular Medicine, Berlin, Germany; † Experimental and Clinical Research Center, and Departments of ‡ Nephrology, § Urology, **Pathology, and †† Gastroenterology, Charité Medical University, Berlin, Germany; | Berlin Institute of Urologic Research, Berlin, Germany A.A. and C.H. contributed equally to this work #Corresponding author: Prof. Dr. Kai M. Schmidt-Ott Max Delbrueck Center for Molecular Medicine Robert-Rössle-Str 10 13125 Berlin, Germany Phone:+49 30 9406 2512 Fax: +49 30 9406 2536 Email: [email protected] Supplements Materials and Methods......................................................................................................................3 Supplemental Figure 1 Grhl2 binding through ChIP-seq and derived target genes by combining ChIP-seq and gene expression data...............................................................................................10 Supplemental Figure 2 Validation of IMCD-3 Grhl2-KD cells...........................................................11 Supplemental Figure 3 Grhl2 ChIP tracks at selected core targets and EMT genes ......................13 Supplemental Figure 4 Characterization of IMCD-3 Grhl2-KD cysts at several time ponits.............14
    [Show full text]
  • Downloaded Were Prepared from NCBI
    G C A T T A C G G C A T genes Article Evidence Supporting the Regulatory Relationships through a Paracrine Pathway between the Sternum and Pectoral Muscles in Ducks Yanying Li 1, Hehe Liu 1,*, Lei Wang 1, Yang Xi 1, Jiwen Wang 1, Rongping Zhang 1, Liang Li 1, Lili Bai 1 and Ahsan Mustafa 2 1 Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, College of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China; [email protected] (Y.L.); [email protected] (L.W.); [email protected] (Y.X.); [email protected] (J.W.); [email protected] (R.Z.); [email protected] (L.L.); [email protected] (L.B.) 2 Institute of Animal Nutrition, Key Laboratory for Animal Disease-Resistance Nutrition of China, Ministry of Education, Sichuan Agricultural University, Chengdu 611130, China; [email protected] * Correspondence: [email protected]; Tel.: +86-028-8629-0985; Fax: +86-028-8629-0987 Abstract: Muscles and bones are anatomically closely linked, and they can conduct communication by mechanical and chemical signals. However, the specific regulatory mechanism between the pectoral muscle and sternum in birds was largely unknown. The present study explored the potential relationship between them in ducks. The result of the sections showed that more nuclei in proliferate states were observed in the pectoral muscle fibers attached to the calcified sternum, than those attached to the un-calcified sternum. The RNA-seq identified 328 differentially expressed genes (DEGs) in the sternum between the calcified and un-calcified groups. Gene ontology (GO) showed Citation: Li, Y.; Liu, H.; Wang, L.; Xi, that the DEGs were mainly enriched in pathways associated with calcification.
    [Show full text]
  • Modeling Gene Regulation from Paired Expression and Chromatin Accessibility Data
    Modeling gene regulation from paired expression and PNAS PLUS chromatin accessibility data Zhana Durena,b,c, Xi Chenb, Rui Jiangd,1, Yong Wanga,c,1, and Wing Hung Wongb,1 aAcademy of Mathematics and Systems Science, National Center for Mathematics and Interdisciplinary Sciences, Chinese Academy of Sciences, Beijing 100080, China; bDepartment of Statistics, Department of Biomedical Data Science, Bio-X Program, Stanford University, Stanford, CA 94305; cSchool of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; and dMinistry of Education Key Laboratory of Bioinformatics, Bioinformatics Division and Center for Synthetic & Systems Biology, Tsinghua National Laboratory for Information Science and Technology, Department of Automation, Tsinghua University, Beijing 100084, China Contributed by Wing Hung Wong, May 8, 2017 (sent for review March 20, 2017; reviewed by Christina Kendziorski and Sheng Zhong) The rapid increase of genome-wide datasets on gene expression, gene expression data, accessibility data are available for a diverse set chromatin states, and transcription factor (TF) binding locations offers of cellular contexts (Fig. 1, blue boxes). In fact, we expect the an exciting opportunity to interpret the information encoded in amount of matched expression and accessibility data (i.e., measured genomes and epigenomes. This task can be challenging as it requires on the same sample) will increase very rapidly in the near future. joint modeling of context-specific activation of cis-regulatory ele- The purpose of the present work is to show that, by using ments (REs) and the effects on transcription of associated regulatory matched expression and accessibility data across diverse cellular factors. To meet this challenge, we propose a statistical approach contexts, it is possible to recover a significant portion of the in- based on paired expression and chromatin accessibility (PECA) data formation in the missing data on binding location and chromatin across diverse cellular contexts.
    [Show full text]
  • Defining the Molecular and Cellular Mechanisms of EZH2's Dynamic Role In
    Defining the Molecular and Cellular Mechanisms of EZH2's Dynamic Role in Tumourigenesis Thomas Mortimer University College London and The Francis Crick Institute PhD Supervisor: Dr Paola Scaffidi A thesis submitted for the degree of Doctor of Philosophy University College London July 2019 Declaration I, Thomas Mortimer confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Epigenetic regulators are recurrently hijacked by cancer cells to enhance and maintain their malignant properties. Remarkably, epigenetic regulators are often co-opted by cancer cells in their wild-type unmutated form without any discernible changes to their intrinsic properties. However, the molecular mechanisms that underlie the co-option of these key regulators of cellular identity remain largely unclear. To generate a mechanistic paradigm for this phenomenon, I investigate how the Polycomb component EZH2 transitions from its physiological role in regulating normal development and tissue maintenance, to its pathological role as a tumour promoter. Focussing on the role of EZH2 in the central nervous system, I show that oncogenic signalling redistributes EZH2 on chromatin, leading to transcriptional misregulation of key neural homeotic genes and a malignant rewiring of normal development programmes. This is achieved by de-repression of spinal cord-specifying HOX genes and repression of the forebrain and neural stem cell transcription factor EMX2, an expression switch observed in both glioblastoma cell lines and patient samples. By in vivo assays, I show that EMX2 is a potent tumour suppressor in glioblastoma, suggesting that EMX2 repression by EZH2 is important for glioblastoma maintenance.
    [Show full text]